Intraoperative spectral-domain OCT was successful in imaging IOL position during standard phacoemulsification, a study found.The prospective study included 101 eyes of 74 patients who underwent standard phacoemulsification and IOL implantation.
Author: Healio ophthalmology
GenSight Biologics becomes first gene therapy company listed in Europe
GenSight Biologics has become the first gene therapy company to be listed in Europe following an initial public offering on Euronext Paris, according to company correspondence.GenSight, founded in 2012 and based in Paris, focuses on the discovery and d…
In memory of Prof. Kazuichi Konyama, 1928 to 2016
It is with great sadness that we announce the passing of Prof. Kazuichi Konyama, a great leader and mentor of ophthalmology in Japan and Thailand and around the Asia-Pacific region.Although Prof. Konyama was born in Kagawa, Japan, he began his medical training in Thailand in the 1950s. In 1960, he received a doctorate from Juntendo University in Tokyo, where he was later an instructor. He also completed a master’s degree in public health from Johns Hopkins University in 1982.
Santen to acquire InnFocus
Santen Pharmaceutical announced it has entered into a definitive agreement to acquire InnFocus, developer of the MicroShunt glaucoma implant device.Santen will acquire InnFocus for an upfront payment of $225 million, plus performance-based consideratio…
Study: Epithelium-on cross-linking not yet hitting goal
Removal of the epithelium is still a crucial step in the cross-linking procedure, according to a study recently published in the Journal of Refractive Surgery.“The modified riboflavin solution containing benzalkonium chloride (BAC-EDTA), which raised hope for the epithelium-on procedure in preclinical studies, has had disappointing results in human,” Farhad Hafezi, MD, PhD, principal investigator, told Ocular Surgery News.
Trachoma elimination moves one step closer with Global Trachoma Mapping Project
A 3-year disease mapping project screening 2.6 million people in 29 countries worldwide provided an unprecedented amount of data on the magnitude, geographic distribution and burden of trachoma. In addition, it is now giving further impetus to the impl…
FDA approves Avedro’s cross-linking system for corneal ectasiafollowing refractive surgery
The FDA has approved the KXL system and two photoenhancers for the treatment of corneal ectasia following refractive surgery, according to an Avedro press release. The KXL system and the two photoenhancers, Photrexa 0.146% (riboflavin 5’-phosphate ophthalmic solution) and Photrexa Viscous 0.146% (riboflavin 5’-phosphate in 20% dextran ophthalmic solution), previously received FDA approval in April for the treatment of progressive keratoconus.
TPG Capital to acquire Beaver-Visitec
TPG Capital has entered into a definitive agreement with RoundTable Healthcare Partners to acquire Beaver-Visitec, according to a RoundTable press release. The transaction will include brands of Beaver blades, Visitec cannulae and instruments, Merocel …
As-needed aflibercept resolves persistent, recurrent fluid in eyes with neovascular AMD
As-needed aflibercept injections improved anatomic outcomes in eyes with recurrent or persistent retinal fluid associated with neovascular age-related macular degeneration, a study found.The retrospective study included 81 eyes of 78 patients with pers…
Allergan submits application to FDA for Oculeve intranasal tear neurostimulator
Allergan has filed a de novo application to the FDA for the Oculeve intranasal tear neurostimulator, according to a company press release. The hand-held stimulator can temporarily increase tear production in patients with dry eye disease due to decreas…
Five most-viewed videos from EGS
The most trending articles on Healio.com/OSN from the European Glaucoma Society Congress were video perspectives from key opinion leaders who shared their perspectives on trending topics related to glaucoma treatment.
VIDEO: Speaker talks use of spot vision screener on patients with developmental disability
At Kiawah Eye, Amanda Limbaugh Marzolf, MD, discusses results of a study looking at the prevalence of amblyopia risk factors in patients with developmental disability with the use of the spot vision screener.
VIDEO: Speaker gives an overview of anterior scleritis
At Hawaiian Eye, Nisha Acharya, MD, MS, discusses the diagnosis and management of anterior scleritis.
VIDEO: Speaker compares OCT systems
At Retina 2016, Andrew A. Moshfeghi, MD, MBA, gives a practical comparison of spectral domain OCT systems.
FDA approves Tecnis Symfony IOLs for cataracts
The FDA has approved the Tecnis Symfony IOL for the treatment of cataracts, Abbott announced in a press release. The approval includes the Tecnis Symfony Toric IOL for people with astigmatism.The Symfony IOLs are the first extended range of vision IOLs approved in the U.S., providing full range of vision after cataract surgery while “mitigating the effects of presbyopia by helping people focus on near objects,” the release said.
DSAEK yields better 5-year graft survival than PK in Asian eyes
Descemet’s stripping automated endothelial keratoplasty resulted in better graft survival than PK in Asian patients with endothelial dystrophy, according to a study.Data were culled from the Singapore Corneal Transplant Registry. The review included 828 consecutive patients who underwent DSAEK (423 eyes) or PK (405 eyes) for bullous keratopathy or Fuchs’ endothelial dystrophy at the Singapore National Eye Center.
Publication Exclusive: Surgeons debate choices for preventing infection after cataract surgery
Prophylactic regimens for preventing infection after cataract surgery are effective, but choosing among the increasing number and combinations of washes, drops and injections is becoming more and more a matter of physician preference and physician deba…
VIDEO: Cataract patient-guidance systems deliver improved patient outcomes
At Kiawah Eye, Stephen Lane, MD, discusses the benefits of using cataract patient-guidance systems to help surgeons deliver improved outcomes for cataract patients.
Laser goniopuncture may enhance IOP lowering of previous surgery
Laser goniopuncture can contribute to IOP reduction after viscocanalostomy or phacoviscocanalostomy, according to a study.Laser goniopuncture is a noninvasive, non-incisional technique performed with an Nd:YAG laser to create a break and open the trabeculo-Descemet’s window to maximize aqueous drainage and reduce IOP.
CMS considers delay in MACRA implementation, AMA approves
The AMA has announced its approval after CMS acting administrator Andrew Slavitt testified before the Senate Finance Committee that the agency was considering “steps to address concerns about physicians’ readiness for implementation of the Medicare Acc…